Financial terms were not disclosed.
The acquisition will include Zarbee’s full line of products, including cough and throat syrups, multivitamins, and immune supplements. The Salt Lake City-based company was founded in 2008 by a pediatrician who wanted to create alternatives to traditional OTC medicine, free of alcohol, drugs and artificial flavors.
"The Zarbee's team has achieved tremendous success in the marketplace and we are excited to be a part of their future growth,” said Kathy Widmer, president, U.S. OTC, Johnson & Johnson Consumer Inc., in a statement. “Upon closing of the transaction, we look forward to working closely with the Zarbee's team as they join the Johnson & Johnson Consumer family."
The transaction is expected to close in the third quarter.
When contacted, a Zarbee’s representative said she hadn’t yet heard about the acquisition and would be seeking information.